I now have comprehensive content from both Robbins textbooks plus all the key diagrams. Let me compile the full 10-mark notes.
ATHEROSCLEROSIS - Pathology Notes (Robbins) - 10 Marks
DEFINITION
Atherosclerosis (Greek: athero = gruel/porridge; sclerosis = hardening) is a chronic inflammatory disease of large and medium-sized arteries characterized by intimal lesions called atheromas (atherosclerotic plaques) - raised lesions with a soft, grumous lipid core covered by a fibrous cap that protrude into vessel lumens and can rupture.
It is the most common cause of morbidity and mortality in the Western world, responsible for ~50% of all deaths.
EPIDEMIOLOGY
- Sites most affected (in decreasing order): Abdominal aorta > coronary arteries > popliteal arteries > descending thoracic aorta > internal carotid arteries > Circle of Willis vessels
- Causes: Ischemic heart disease (MI), stroke, aortic aneurysm, peripheral vascular disease
- Death rate in Eastern Europe is 3-5x higher than the USA; Africa, India, Southeast Asia rates now exceed the USA
RISK FACTORS
FLOW CHART: Risk Factors
RISK FACTORS FOR ATHEROSCLEROSIS
│
├── NON-MODIFIABLE (Constitutional)
│ ├── Genetics / Family history (most important independent RF)
│ ├── Age (incidence of MI increases 5x between ages 40-60)
│ ├── Male sex (premenopausal females relatively protected by estrogen)
│ └── Clonal hematopoiesis (CHIP - pro-inflammatory monocytes)
│
└── MODIFIABLE
├── MAJOR
│ ├── Hyperlipidemia (↑LDL, ↓HDL, ↑Lp[a]) ← most important
│ ├── Hypertension
│ ├── Cigarette smoking
│ └── Diabetes mellitus
│
└── ADDITIONAL / EMERGING
├── Inflammation (↑CRP, IL-6)
├── Hyperhomocysteinemia
├── ↑Plasminogen activator inhibitor-1
├── Lipoprotein(a) [Lp(a)]
├── Obesity
└── Physical inactivity
Key point - Hyperlipidemia:
- ↑LDL cholesterol = most important modifiable RF
- ↓HDL = independent risk factor (HDL promotes cholesterol efflux/reverse transport)
- LDL-lowering with statins reduces risk of MI by ~30%
- Oxidized LDL is far more atherogenic than native LDL
PATHOGENESIS
The currently accepted model is the "Response to Injury" Hypothesis (Ross, 1976, updated). Atherosclerosis is viewed as a chronic inflammatory response of the arterial wall to endothelial injury.
FLOW CHART: Pathogenesis of Atherosclerosis
ENDOTHELIAL INJURY / DYSFUNCTION
(Hyperlipidemia, HTN, Smoking, Hemodynamic turbulence, Toxins)
│
▼
ENDOTHELIAL DYSFUNCTION
• ↑Permeability to lipoproteins
• ↑Leukocyte adhesion molecule expression (VCAM-1, ICAM-1)
• Pro-thrombotic state
• ↓Nitric oxide (vasodilatory, anti-inflammatory)
│
├──────────────────────────────────────────┐
▼ ▼
LDL ACCUMULATION IN INTIMA MONOCYTE ADHESION & MIGRATION
• LDL oxidized by free radicals into intima
• Oxidized LDL is cytotoxic to ECs ↓
• Triggers further inflammation MACROPHAGES (via M-CSF)
│ + FOAM CELLS
└────────────────┬─────────────┘
▼
FATTY STREAK FORMATION
(earliest lesion - yellow intimal discoloration)
Foam cells = macrophages + SMCs engorged with lipid
│
▼
PLATELET ADHESION
(exposed subendothelial collagen)
│
▼
RELEASE OF GROWTH FACTORS & CYTOKINES
(PDGF from platelets, macrophages, ECs)
(FGF, TGF-α, TNF, IL-1, MCP-1)
│
▼
SMC RECRUITMENT (from media → intima)
SMC PROLIFERATION + ECM SYNTHESIS
(collagen, proteoglycans → FIBROUS CAP)
│
▼
ADVANCED ATHEROSCLEROTIC PLAQUE
• Fibrous cap (collagen, SMCs, macrophages)
• Necrotic/lipid core (foam cell debris,
cholesterol crystals, calcium)
• Shoulder region (most inflammatory)
Key cellular players:
| Cell | Role |
|---|
| Endothelial cells | Injury triggers the whole cascade; become dysfunctional |
| Monocytes/Macrophages | Engulf oxidized LDL → foam cells; release cytokines (TNF, IL-1, MMP) |
| Smooth muscle cells | Migrate from media → intima; proliferate; synthesize collagen (fibrous cap) |
| T lymphocytes | Produce IFN-γ → inhibit SMC collagen synthesis → plaque destabilization |
| Platelets | Adhere to injured endothelium; release PDGF, TGF-β |
MORPHOLOGY
Gross Appearance
1. Fatty Streak (earliest lesion)
- Flat or slightly raised yellow intimal streak or spot
- Composed of foam cells (lipid-laden macrophages + SMCs)
- Reversible - can appear in aorta of infants/children (harmless at this stage)
- Precursor to atherosclerotic plaques
2. Atherosclerotic (Fibrous/Atheromatous) Plaque
- Yellow-white raised intimal lesion, 0.3-1.5 cm diameter
- May coalesce → larger plaques
- Eccentric distribution (not circumferential)
- Patchy, irregular distribution throughout the vessel
Components of a Mature Plaque (Microscopic)
LUMEN
│
▼
┌─────────────────────────────────┐
│ FIBROUS CAP │
│ • SMCs, macrophages, foam │
│ cells, T lymphocytes │
│ • Collagen, elastin, │
│ proteoglycans │
│ • Neovascularization │
│ SHOULDER (most vulnerable │
│ to rupture - most inflamed) │
├─────────────────────────────────┤
│ NECROTIC/LIPID CORE │
│ • Cell debris │
│ • Cholesterol crystals │
│ • Foam cells │
│ • Calcium deposits │
│ • Intraplaque hemorrhage │
│ (rupture of vasa vasorum) │
└─────────────────────────────────┘
│
MEDIA (compressed, may atrophy)
│
ADVENTITIA
Textbook Robbins Diagram - Atheromatous Plaque Structure:
Fig. 8.5B - Robbins & Kumar Basic Pathology: Fibrous cap (containing SMCs, macrophages, foam cells, lymphocytes, collagen, elastin, proteoglycans, neovascularization) overlying a Necrotic center (cell debris, cholesterol crystals, foam cells, calcium). Shoulder areas are the sites most prone to rupture.
PATHOGENESIS DIAGRAM (Robbins Classic)
Robbins Fig. 8.8 - Step-by-step progression: (1) Chronic endothelial injury from hyperlipidemia, HTN, smoking, hemodynamic factors → (2) Endothelial dysfunction with monocyte adhesion and platelet adhesion → (3) Macrophage activation, SMC recruitment, lipid accumulation (Fatty streak) → (4) Macrophages and SMCs engulf lipid (Fibrofatty atheroma) → (5) SMC proliferation, collagen/ECM deposition, extracellular lipid accumulation → Advanced plaque with foam cells, lipid debris, collagen
STABLE VS. VULNERABLE PLAQUE
Robbins Fig. 8.14 - Stable plaques: thick fibrous cap, small lipid core, minimal inflammation. Vulnerable plaques: thin fibrous cap, large lipid core, marked inflammation - prone to rupture.
| Feature | Stable Plaque | Vulnerable Plaque |
|---|
| Fibrous cap | Thick | Thin |
| Lipid core | Small | Large |
| Inflammation | Minimal | Marked (foamy macrophages, T cells) |
| SMC content | High | Low |
| Collagen | Abundant | Reduced (MMPs degrade it) |
| Risk | Angina (stable) | ACS, MI, sudden death |
CONSEQUENCES / COMPLICATIONS
FLOW CHART: Complications of Atherosclerosis
ATHEROSCLEROTIC PLAQUE
│
├──── GRADUAL STENOSIS (>70% occlusion)
│ → Chronic ischemia
│ → Stable angina
│ → Intermittent claudication
│ → Mesenteric ischemia
│
├──── ACUTE PLAQUE CHANGE (rupture/erosion)
│ │
│ THREE TYPES:
│ 1. Rupture/Fissuring → exposed thrombogenic core
│ → THROMBOSIS (occlusive)
│ → MYOCARDIAL INFARCTION
│ → ISCHEMIC STROKE
│ → SUDDEN CARDIAC DEATH
│ 2. Erosion/Ulceration → exposed subendothelial
│ basement membrane
│ → partial thrombosis
│ 3. Intraplaque Hemorrhage → rupture of vasa vasorum
│ → rapid plaque expansion
│
├──── ATHEROEMBOLISM
│ • Plaque debris → microemboli downstream
│ • Can cause renal failure, bowel ischemia
│
└──── ANEURYSM FORMATION
• Plaque ischemia of media
• SMC loss + ECM degradation in media
• Weakens wall → dilatation
→ Abdominal Aortic Aneurysm (AAA) most common
→ Risk of rupture → hemorrhage → death
LESION SEQUENCE (AHA Classification)
TYPE I - Initial lesion
(isolated macrophage foam cells)
↓
TYPE II - Fatty streak
(multiple foam cell layers; visible yellow streaks)
[REVERSIBLE STAGE]
↓
TYPE III - Intermediate lesion
(foam cells + small extracellular lipid pools)
↓
TYPE IV - Atheroma
(large lipid core = "gruel"; endothelium intact)
↓
TYPE V - Fibroatheroma
(lipid core + fibrous cap = classic plaque)
[MOST CLINICALLY SIGNIFICANT]
↓
TYPE VI - Complicated lesion
(surface defect, hematoma, hemorrhage, thrombosis)
[CAUSES ACUTE EVENTS - MI, STROKE]
KEY MOLECULES SUMMARY TABLE
| Molecule | Source | Effect |
|---|
| Oxidized LDL | Oxidation of LDL in intima | Cytotoxic to ECs; stimulates foam cell formation |
| MCP-1 (CCL2) | Endothelial cells, SMCs | Recruits monocytes into intima |
| VCAM-1 | Dysfunctional endothelium | Adhesion of monocytes and T cells |
| PDGF | Platelets, macrophages, ECs | Stimulates SMC migration + proliferation |
| M-CSF | ECs, macrophages | Macrophage differentiation and activation |
| IFN-γ | T lymphocytes | Inhibits SMC collagen synthesis → cap weakening |
| MMPs (metalloproteinases) | Macrophages, foam cells | Degrade collagen → plaque instability |
| IL-1, TNF | Macrophages | Pro-inflammatory; upregulate adhesion molecules |
| HDL | Liver | Reverse cholesterol transport; protective |
| hsCRP | Liver (acute phase) | Marker of inflammation; independent risk predictor |
IMPORTANT EXAM POINTS (10-Mark Answer Tips)
- Definition: Chronic inflammatory disease of large/medium arteries - always mention "response to injury hypothesis"
- Fatty streak = earliest lesion - foam cells - reversible
- Plaque components: Fibrous cap (collagen, SMCs) + Necrotic core (lipid, calcium, debris)
- Vulnerable plaque = thin cap + large lipid core + marked inflammation = rupture → ACS
- Sites: Abdominal aorta > coronary > popliteal arteries
- Complications: Stenosis, thrombosis (MI, stroke), aneurysm, atheroembolism
- Role of oxidized LDL as central pathogenic molecule
- Foam cells = macrophages + SMCs engorged with oxidized LDL via scavenger receptors
REFERENCES
- Robbins & Kumar Basic Pathology, 11th ed. - Chapter 8 (Vascular Diseases), pp. 316-324
- Robbins, Cotran & Kumar Pathologic Basis of Disease, 10th ed. - Chapter 11 (Blood Vessels), pp. 466-478